All News #Library
Rare Diseases
VeonGen`s VG801 Therapy for Stargardt Gets FDA RMAT Designation
21 Aug 2025 //
GLOBENEWSWIRE
ViGeneron Rebrands, Gains FDA RPDD for VG801 in Stargardt
05 Jun 2025 //
GLOBENEWSWIRE
ViGeneron Gets Rare Pediatric Designation For VG901 Retinitis Trial
08 Jan 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support